Ring fused pyrazole derivatives

Details for Australian Patent Application No. 2002356725 (hide)

Owner F. Hoffmann-La Roche AG

Inventors O'Yang, Counde; Loughhead, David Garrett

Agent Spruson & Ferguson

Pub. Number AU-B-2002356725

PCT Number PCT/EP02/13267

PCT Pub. Number WO2003/048160

Priority 60/336,751 04.12.01 US; 60/408,613 06.09.02 US

Filing date 26 November 2002

Wipo publication date 17 June 2003

Acceptance publication date 17 July 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 31/444 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/06 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 5/04 (2006.01) Drugs for disorders of the endocrine system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/06 (2006.01) Drugs for genital or sexual disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 60/336,751 04.12.01 US; 60/408,613 06.09.02 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002356725

17 July 2008 Application Accepted

  Published as AU-B-2002356725

13 November 2008 Standard Patent Sealed

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002356726-REGULATION OF HUMAN SERINE/ THREONINE PROTEIN KINASE

2002356724-CUTLERY BASKET FOR A DISHWASHER